We are the leading information aggregator, facilitates and supports the business information needs. With over 90,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
Oct
21
Bharatbook.com : Market Overview of Pharmaceuticals Industry in India
ByIndian Pharmaceuticals Industry Report ( http://www.bharatbook.com/Market-Research-Reports/Indian-Pharmaceuticals-Industry.html ) gives profiles of Indian Pharmaceutical Industry.
Introduction The Indian pharmaceutical industry grew at 13% during 2003-2007, driven by rising consumption levels in the country and strong demand from export markets. In 2006-07, the Indian pharma market reached US$ 8.16 billion and is estimated to reach US$ 9.77 billion in 2007-08. At present, India’s pharmaceutical industry constitutes 1-2% of the global pharmaceutical market in value terms. Key Findings & Highlights - The market is estimated to register sales of US$ 743 billion in 2008 with a growth of 5-6% compared with 6-7% in 2007. - In 2007, 71% of oncology product sales came from the US and Europe’s top five markets—France, Germany, Italy, the UK and Spain. - The growth accelerates in the seven “pharmerging” markets of China, Brazil, Mexico, - South Korea, India, Turkey and Russia and is expected to grow by 12–13% in 2008 to US$ 85–90 billion. - Generic producing companies Barr, Ranbaxy, Mylan, Teva, Actavis and Dr Reddy’s Labs have become dominant as they keep launching more and more generics. - In world rankings, the Indian pharmaceutical industry stood fourth in terms of volume and 13th in terms of value in 2006-07. - Exports are bifurcated into exports services comprising contract manufacturing, contract research. - India currently has more than 80 FDA-approved plants, followed by Italy (55) and China (27). Your Questions Answered - What is the expected growth in the seven “pharmerging” markets across the world? - What is the % of product sales came from US & Europe’s Top five markets? - What are the primary growth drivers in pharma industry? - Why companies are increasingly turning to licensing? - What are the drugs dominated domestic retail pharma market in 2007?
Contact us at:Bharat Book BureauTel: 91 22 27578668Fax: 91 22 27579131Email: info@bharatbook.comWebsite: www.bharatbook.com
